Diabetes mellitus is one of the most significant problems of health care in the world, and selfmanagement is the key that prevents complications and optimizes the long-term prognosis. And two key cornerstones of proper diabetes self-management are medication compliance and regular monitoring of the level of blood glucose. Nevertheless, several factors, including psychosocial factors, behavioral factors, and systemic factors make it very difficult for many patients to maintain these behaviors. Mobile health (mHealth) interventions, especially m-applications, SMS-reminders, and online platforms, have been developed in recent years to be scalable self-management aids to diabetic populations. Although according to each study, some benefits are possible, results are dissimilar or circumstantial, and thus, generalization cannot be easily made. The proposed meta-analysis will help to assess and compare mobile apps, SMS intervention programs, and digital health portals, their roles in promoting medication adherence and glucose monitoring among diabetic patients. The randomized controlled trials published between 2010 and 2025 were identified through a systematic search of major databases such as PubMed, Scopus, Web of Science, and Cochrane Library. Data were extracted separately during the screened studies and extracted using predetermined eligibility criteria. A random-effects model of meta-analytic evaluation was implemented in determining pooled effect sizes, and subgroup investigations aimed at determining intervention-specific results were executed. The findings show
Akter et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: